Search Results 2651-2660 of 25593 for oral

  1. A Study to Evaluate the Effectiveness and Safety of D-PLEX in the Prevention of Sternal Infection Post- Cardiac Surgery - Mayo Clinic

    Participation eligibility · Subjects undergoing partial sternotomy. · Subjects with any preoperative active significant infection. · Subjects that received oral or ...

  2. Lyme disease - Diagnosis and treatment - Mayo Clinic

    A review of all signs and symptoms. A history of known or possible exposure to ticks. Blood tests to find disease-fighting antibodies to the bacteria.

  3. Soft tissue sarcoma - Doctors and departments - Mayo Clinic

    John M. Nathan, M.D., D.D.S.. Sleep Medicine Specialist; Oral and Maxillofacial Surgeon; Surgeon. Rochester, MN ...

  4. Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease - Mayo Clinic

    Oral 5-aminosalicylate (5-ASA) compounds provided the dose prescribed has been stable for at least 4 weeks prior to randomization; dose must remain stable ...

  5. Low blood cell counts: Side effects of cancer treatment - Mayo Clinic

    Find out why your doctor tests your blood during cancer treatment and what signs and symptoms may signal a low blood cell count.

  6. Gallstones - Diagnosis & treatment - Mayo Clinic

    Other imaging tests. Additional tests may include oral cholecystography, a hepatobiliary iminodiacetic acid (HIDA) scan, computerized tomography (CT), magnetic ...

  7. Publications - William L. Hasler, M.D. - Mayo Clinic

    Impact of gastric per-oral endoscopic myotomy on static and dynamic pyloric function in gastroparesis patients. Neurogastroenterol Motil. 2020 Nov; 32 (11): ...

  8. Omalizumab (subcutaneous route) - Mayo Clinic

    Omalizumab injection is used to treat moderate to severe persistent allergic asthma. It is used when a patient's asthma has not been controlled sufficiently on ...

  9. Ribociclib and Gemcitabine Hydrochloride in Treating Patients With Advanced or Metastatic Solid Tumors - Mayo Clinic

    Note: Therapy with heparin, direct oral anticoagulants, low molecular weight heparin (LMWH) or fondaparinux is allowed. Participation in a prior ...

  10. A Study of CNTO 136 (Sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy (SIRROUND-T) - Mayo Clinic

    If using oral ... If currently not using corticosteroids, must not have received oral corticosteroids for at least 2 weeks prior to the first administration of ...